Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to demonstrate non-inferiority in terms of the percentage of subjects who have plasma HIV-1 RNA levels <50 copies/mL after 48 weeks of follow-up after switching to DRV/rtv monotherapy versus triple therapy containing DRV/rtv (FDA Snapshot method).
Inclusion criteria
- HIV-1 infection